Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 29, 2024
Total Value: $459M (99.3% shares, 0.7% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX INC | 6,653,138 | $60.54M | 13.2% | $5.10 | +39.3% | COM | 67576A100 |
| HROW | HARROW HEALTH INC | 3,920,600 | $51.87M | 11.3% | $6.18 | +72.5% | COM | 415858109 |
| TGTX | TG THERAPEUTICS INC | 2,280,000 | $34.68M | 7.6% | $13.67 | +16.6% | COM | 88322Q108 |
| KROS | KEROS THERAPEUTICS INC | 367,500 | $24.33M | 5.3% | $47.67 | +24.4% | COM | 492327101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 515,000 | $22.31M | 4.9% | $12.73 | +243.7% | COM | 76243J105 |
| CPRX | CATALYST PHARMACEUTICALS INC | 1,004,355 | $16.01M | 3.5% | $13.39 | +12.6% | COM | 14888U101 |
| ARVN | ARVINAS INC | 330,000 | $13.62M | 3.0% | $27.46 | +59.1% | COM | 04335A105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 897,000 | $13.29M | 2.9% | $6.29 | +85.1% | COM | 462260100 |
| JSPR | JASPER THERAPEUTICS INC | 435,573 | $12.79M | 2.8% | $17.76 | 0.0% | COM NEW | 471871202 |
| EWTX | EDGEWISE THERAPEUTICS INC | 665,000 | $12.13M | 2.6% | $10.13 | +57.0% | COM | 28036F105 |
| — | APPLIED THERAPEUTICS | 1,770,000 | $12.04M | 2.6% | $4.24 | — | COM | 03828A101 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 344,123 | $10.96M | 2.4% | $20.37 | +25.3% | COM | 35104E100 |
| CDXS | CODEXIS INC | 3,120,000 | $10.89M | 2.4% | $2.52 | +25.1% | COM | 192005106 |
| TARA | PROTARA THERAPEUTICS INC | 2,692,594 | $10.8M | 2.4% | $29.10 | -88.9% | COM STK | 74365U107 |
| — | ACELYRIN INC | 1,580,000 | $10.66M | 2.3% | $20.90 | — | COM | 00445A100 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 210,000 | $9.83M | 2.1% | $20.62 | +89.8% | COM | 22663K107 |
| ETON | ETON PHARMACEUTICALS INC | 2,445,781 | $9.172M | 2.0% | $5.82 | -24.9% | COM | 29772L108 |
| TRVI | TREVI THERAPEUTICS INC | 2,645,000 | $9.125M | 2.0% | $2.06 | +8.5% | COM | 89532M101 |
| — | LYELL IMMUNOPHARMA INC | 3,355,000 | $7.482M | 1.6% | $2.23 | — | COM | 55083R104 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 315,388 | $7.459M | 1.6% | $10.93 | +85.8% | ORDINARY SHARES | N62509109 |
| VTYX | VENTYX BIOSCIENCES INC | 1,285,000 | $7.067M | 1.5% | $8.94 | -48.9% | COM | 92332V107 |
| NTLA | INTELLIA THERAPEUTICS INC | 255,000 | $7.015M | 1.5% | $28.15 | -1.3% | COM | 45826J105 |
| CMPX | COMPASS THERAPEUTICS INC | 3,170,000 | $6.277M | 1.4% | $1.73 | 0.0% | COM | 20454B104 |
| XOMA | XOMA CORP DEL | 250,000 | $6.013M | 1.3% | $11.26 | +99.0% | COM NEW | 98419J206 |
| LQDA | LIQUIDIA CORPORATION | 395,000 | $5.826M | 1.3% | $5.52 | +151.8% | COM NEW | 53635D202 |
| PCVX | VAXCYTE INC | 85,000 | $5.806M | 1.3% | $38.73 | +78.8% | COM | 92243G108 |
| NYXH | NYXOAH S A | 320,000 | $4.317M | 0.9% | $7.81 | +46.2% | SHS | B6S7WD106 |
| SVRA | SAVARA INC | 855,000 | $4.258M | 0.9% | $4.83 | 0.0% | COM | 805111101 |
| SYRS | SYROS PHARMACEUTICALS INC | 787,545 | $4.213M | 0.9% | $5.32 | +29.9% | COM NEW | 87184Q206 |
| URGN | UROGEN PHARMA LTD | 270,000 | $4.05M | 0.9% | $8.22 | +98.9% | COM | M96088105 |
| NRIX | NURIX THERAPEUTICS INC | 267,210 | $3.928M | 0.9% | $10.76 | 0.0% | 67080M103 | 67080M103 |
| — | REVANCE THERAPEUTICS INC | 785,000 | $3.862M | 0.8% | $4.92 | — | COM | 761330109 |
| RLMD | RELMADA THERAPEUTICS INC | 759,000 | $3.529M | 0.8% | $2.96 | +62.7% | COM | 75955J402 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 112,700 | $3.26M | 0.7% | $17.50 | +55.5% | COM | 74366E102 |
| — | GOSSAMER BIO INC | 8,000,000 | $3.213M | 0.7% | $0.39 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 200,000 | $3.152M | 0.7% | $13.75 | 0.0% | COM | 98943L107 |
| — | ALLAKOS INC | 2,435,000 | $3.068M | 0.7% | $1.26 | — | COM | 01671P100 |
| GOSS | GOSSAMER BIO INC | 2,440,109 | $2.879M | 0.6% | $1.22 | -9.6% | COM | 38341P102 |
| IBIO | IBIO INC | 680,000 | $2.761M | 0.6% | $1.26 | 0.0% | COM NEW | 451033708 |
| VSTM | VERASTEM INC | 211,400 | $2.495M | 0.5% | $8.32 | +38.9% | COM NEW | 92337C203 |
| — | ALIGOS THERAPEUTICS INC | 1,630,000 | $1.597M | 0.3% | $0.73 | — | COM | 01626L105 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,108,357 | $1.53M | 0.3% | $1.08 | +4.1% | COM | 21077P108 |
| PGEN | PRECIGEN INC | 947,500 | $1.374M | 0.3% | $1.40 | +2.8% | COM | 74017N105 |
| LRMR | LARIMAR THERAPEUTICS INC | 174,413 | $1.324M | 0.3% | $7.31 | +6.6% | COM | 517125100 |
| FULC | FULCRUM THERAPEUTICS INC | 130,000 | $1.227M | 0.3% | $4.44 | +101.2% | COM | 359616109 |
| — | MORPHOSYS AG | 65,000 | $1.179M | 0.3% | $3.87 | — | SPONSORED ADS | 617760202 |
| GKOS | GLAUKOS CORP | 8,576 | $809K | 0.2% | $89.35 | 0.0% | COM | 377322102 |
| PMVP | PMV PHARMACEUTICALS INC | 471,481 | $802K | 0.2% | $1.87 | 0.0% | COM | 69353Y103 |
| — | BIODESIX | 534,657 | $765K | 0.2% | $6.34 | — | COM | 09075X108 |
| — | REGULUS THERAPEUTICS INC | 170,308 | $490K | 0.1% | $2.88 | — | COM | 75915K309 |
| DSGN | DESIGN THERAPEUTICS INC | 113,038 | $456K | 0.1% | $2.67 | 0.0% | COM | 25056L103 |
| — | REPARE THERAPEUTICS iNC | 67,561 | $318K | 0.1% | $4.71 | — | COM | 760273102 |